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Abstract
Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are frequently prescribed to relieve pain and
inflammation. These NSAIDs have also analgesic effects and can be administered via oral, injectable, and
topical routes. During inflammation, a number of synovial mediators and cytokines are released which
decrease the pH level of the synovial fluid. Administration of acidic NSAIDs further decreases the pH
levels and hence contributes to the destruction of the cartilage. To our knowledge, no cellular-based study
regarding the chondrotoxicity of phenyl alkanoic acid derivatives on NSAIDs was conducted before. Thus,
the aim of this pioneering study was to examine the effect of frequently prescribed NSAIDs, a phenyl
alkanoic acid derivative, flurbiprofen, on the proliferation and differentiation of human primer chondrocyte
cultures in vitro.
Methods: Primer chondrocyte cultures were prepared from osteochondral tissue obtained during surgery
for gonarthrosis. Samples not exposed to the pharmacological agent were used as the control group. The samples
were treated with 1, 10, 100, 250, 500, or 1000 μM of the agent for 24, 48, and 72 h. The cell viability, toxicity, and
proliferation were assessed with MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) analysis and
prechondrocytic precursor stage-specific embryonic antigen-1 (SSEA-1) expression using a commercial ELISA
kit spectrophotometrically. The surface morphology of the samples in each group was compared using an
inverted light microscope and an environmental scanning electron microscope (ESEM). An analysis of variance
was used to compare between-group differences. Tukey’s honest significant difference (HSD) method (95 %
confidence interval) was used to evaluate the differences and significance in averages. The alpha significance
value was considered <0.01.
Results: Statistically significant cytotoxicity was observed in the treatment groups. NSAID had a significant
negative effect on the proliferation and differentiation of chondrocytes as compared to the control group
(p < 0.01).
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Conclusion: Before administering phenyl alkanoic acid derivatives in the clinical setting, their role in
suppressing the proliferation and differentiation of chondrocytes should be taken into account. Thus,
caution should be given when prescribing these drugs.
Keywords: Phenyl alkanoic acid, Chondrotoxicity, Proliferation, Stage-specific, Embryonic, Antigen-1
Background
During cartilage production and degradation cycles,
equilibrium exists between the amount of catabolic cyto-
kines like interleukin-I, tumor necrosis factor alpha,
nitric oxide, matrix metallopreoteinases, and their inhib-
itors. Hence, it can be possible to establish a balance be-
tween the levels of collagen types I and II, which are
responsible for the increased fibrocartilage and hyaline
cartilage production, respectively [1–5]. Moreover, in
order to maintain this equilibrium, the pH values of the
environment that the cartilage tissue resides should be
within the alkaline range. In case the pH values decrease
and the cartilage tissue is surrounded by a rather acidic
milieu, a degeneration process is inevitable and overt
signs of cartilage toxicity may be witnessed [6, 7].
During the course of the chronic disorders including
rheumatoid arthritis, osteoarthritis, ankylosing spondyl-
itis, tendinitis, bursitis, gout, and juvenile chronic arth-
ritis, a number of substances are released into the
medium following tissue damage and a concomitant
decrease in the activity of the inhibitor mechanisms is
observed. These conditions are characterized by signifi-
cant inflammation and increasing levels of pain in the
affected regions of the body. The inflammation has also
the propensity to decrease the pH levels and render the
milieu more acidic. Furthermore, the drugs employed to
relieve pain and inflammation, specifically non-steroidal
anti-inflammatory drugs (NSAIDs), are known to de-
crease the pH levels to more acidic values. As a conse-
quence, pain, cartilage tissue damage, and functional
deficits become inevitable [8].
A similar problem is also experienced following sino-
nasal or septal surgeries. Irrespective of the method uti-
lized, either conventional septoplasty, radiofrequency, or
LASER, a significant and unpredictable amount of cartil-
age injury was reported to occur [9, 10]. Following these
surgeries, the patients usually receive NSAID’s for the
relief of pain and the synergistic effect of these negative
factors are usually being overlooked.
To suppress inflammation and pain, a number of non-
steroidal anti-inflammatory drugs, which also have anal-
gesic activities, are usually prescribed [8]. However,
majority of these drugs are composed of organic acids
and within the circulation they display great affinity for
binding to the plasma proteins. It is well known that,
following an inflammation process, the pH values
become acidic and the tissue becomes more permeable
to the plasma proteins. These factors enable accumula-
tion of the plasma protein-bound NSAID’s in the in-
flamed region. The decreased pH levels also increase the
amount of the non-ionized lipid soluble portion of the
drug, which in turn increase the interaction between the
lipid structures of the cell membranes and the drug [11].
The literature review revealed that the reliability of
these drugs which act as non-selective inhibitors of
cyclooxygenase-1 and cyclooxygenase-2 isoenzymes are
still under debate due to their potential and unpredict-
able gastrointestinal, hepatic, renal, hematological, and
cardiac side effects [12–16].
The side effects of NSAID’S may also range from
idiosyncratic skin eruptions to photosensitivity, erty-
hema multiforme, leukocytoclastic vasculitis, and toxic
epidermal necrolysis [17, 18]. NSAID’s were reported
to exert adverse effects on patients with asthma, nasal
polyps, and rhinitis [19]. These drugs were also found
to be associated with tinnitus, hearing loss, coma,
confusion, hallucination, depression, headache, syn-
cope spells, dementia, personality changes, and cogni-
tive dysfunction [20].
Attempts to repair the damaged tissues via biological
methods were found to be intriguing by the orthopedic
surgeons, as well as the researchers from other fields of
medicine, and focus was given to conduct researches to
protect or repair the damaged tissues, primarily the
“joint cartilage” [1, 2].
Surprisingly, although it is evident that NSAID’s have
both (i) a significant impact on a number of synovial
mediators (e.g., cytokines) of a complex inflammatory
process which have the potential to modify the chondro-
blastic and chondroclastic activity and (ii) an ability to
further impair cartilage viability by decreasing the pH
values in the inflammation site, to the best of our know-
ledge, no research investigating the possible chondro-
toxic potentials of these organic acid-based drugs at the
molecular level was conducted so far [1–5, 20–23].
The joint cartilage is devoid of neural, vascular, and
lymphatic structures and nourished by passive and active
transport processes. Since the outer portion of the
synovial tissue is richer in terms of vascular supply, the
nutrients first diffuse from the synovial tissue to the syn-
ovial fluid by diffusion. Then, the nutrients are trans-
ferred to the chondrocytes by either a second diffusion
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process that takes place through the pores within the
cartilage or an active transport process in which the
intermittently loaded pumps are used [24, 25]. Although
the diffusion rates of NSAID’s are slower than other
molecules and the concentrations of these drugs in the
synovial fluids are rather stable, even short acting
NSAID’s were reported to accumulate in the synovial
fluid in concentrations slightly lower than their plasma
concentrations [26].
In this research, the impact of flurbiprofen, a phenyl
alkanoic derivative and the most frequently used NSAID,
on the proliferation and differentiation of the human
primary chondrocyte cultures were assessed in vitro
using molecular biology techniques.
Methods
Materials
Collagenase type II enzyme (1 mg/ml) was purchased
from Invitrogen Corporation. Hank’s balanced salt
solution (HBSS)-1× (Cat ≠ 14025), Gibco penicillin-
streptomycin, fetal calf serum, and Dulbecco’s modified
Eagle’s medium (1000 mg glucose/L) were obtained from
Sigma Chemical, St. Louis, USA. Sodium dodecyl sulfate
(SDS) (Cat ≠ L4522), insulin-transferrin-selenous acid
premix, and RPMI-1640 were obtained from Sigma-
Aldrich Gmbh (Germany), and flurbiprofen (Majezik
100 mg) was supplied by Sanovel Corporation, Turkey.
A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) commercial kit, (Vybrant MTT cell
Proliferation assay (Cat ≠ V-13154), was purchased
from Cell Biolabs, United States of America (USA).
Stage-specific embryonic antigen-1 (SSEA-1; Human
Mesenchymal Stem Cell Characterization Kit (Cat ≠
K36094-21A) was supplied from Celprogen Stem Cells
Research and Therapeutics, CA, USA.
A laminar current cabinet (Cat ≠NF–800 R) and incu-
bator (Cat ≠ 06750) were supplied by the Nuve Company
in Ankara, Turkey. Inverted light microscope (Cat ≠
CKX41, Olympus, USA) was used to monitor cell cul-
tures. The images of cultures were obtained and proc-
essed using the Olympus cell soft imaging system
program. MTT analysis and SSEA-1 protein expression
values were determined using an ELISA reader (Mindray
MR 96 A, PRC). Electron micrographs of cell cultures
were obtained with an environmental scanning electron
microscope (ESEM) (Quanta 250 FEG, Fei Company,
Hillsboro, Oregon, USA).
Study design and eligibility criteria
The researchers were blinded to the active ingredients in
the NSAID applied in the cultures. All experiments were
conducted in triplicate.
No drug was administered to primary chondrocyte
cultures in group 1, and this group was used as the
control group. The other groups were treated with 1 μM
(group II), 10 μM (group III), 100 μM (group IV),
250 μM (group V), 500 μM (group VI), or 1000 μM
(group VII) of flurbiprofen.
After 24, 48, and 72 h, the cell viability, toxicity, and
proliferation, in addition to the expression levels of the
SSEA-1 protein, which is a prechondrocytic precursor,
were assessed using spectrophotometry. The surface
morphology of the samples was simultaneously com-
pared and evaluated using an inverted light microscope
and ESEM.
Osteochondral tissues were obtained from patients
(n = 17) with gonarthrosis who applied to the ortho-
pedics and traumatology clinic and underwent total
knee arthroplasty surgery. Of the 17 patients, tissues
from those who had used NSAIDs (n = 5), disease-
modifying antirheumatic drugs (DMARDs) (n = 4),
and biological agents (n = 2) in the last month were
excluded. Thus, tissues from six cases were included
in this study.
Isolation and cell culture of primer human chondrocytes
and application of the flurbiprofen to chondrocyte cultures
Osteochondral tissues from the proximal ends of the
tibia and femur distal of the patients were resected dur-
ing the total knee arthroplasty surgery (Fig. 1). These tis-
sues were placed in a medium and transferred to the
laboratory in aseptic conditions. The chondral tissues
were separated from osteochondral tissues. The tissue
samples were digested mechanically by a rongeur and
enzymatically with collagenase type II enzyme, solubi-
lized in HBSS and incubated at a humidified, 37 °C, 5 %
CO2 incubator for 16 h. After incubation, digested tissue
was centrifuged at 1000 rpm for 3 min and transferred
to culture flasks to obtain chondrocyte primary cultures.
Viable and attached cells were stained by trypan blue
and counted. 1.5 × 104 well/cell were placed in 96-well
plates (for ELISA), 3.3 × 104 well/cell were placed in 24-
well plates (for SSEA-1), and 4.4 × 106 cells were placed
in a 10-mm petri dish for further experiments (for
ESEM and invert microscopy) [1, 2, 27–30].
The flurbiprofen solutions were delivered in lightproof
bottles to the researchers to do the analyses following
letter coding. The researchers were blinded to the cases
and also to the administered drugs.
Microscopic analyses
Micro images of the cell organization of the cartil-
aginous tissue were recorded using phase-contrast
confocal microscopy at magnifications of ×4, ×10,
×20, and ×40 before and after drug administrations.
The Olympus Imaging System program was used to
process the images.
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To shed light on the surface topography and composi-
tions of the chondrocytes, ESEM analysis was per-
formed. In addition to cell morphology, extracellular
matrix and characteristic structures of cell micro envir-
onment were recorded with ESEM.
To perform ESEM, cacodylate and glutaraldehyde buf-
fer was used for fixation. Cell culture medium was re-
moved with a gun pipettor and chondrocytes incubated
with 2.5 % cacodylate and glutaraldehyde buffer for 2 h
at room temperature. Afterwards, the samples were
washed three times in pure cacodylate tampon and then
analyzed [1, 2, 27–30].
Field emission guns (FEG) ion pumps were used for
high vacuum. The images were recorded at a pressure of
220–221 Pa in ESEM vacuum mode, at a magnification
of ×5000, resolutsion depth (HFW) of 82.9 μm, operat-
ing voltage of 5.00 kV, and wavelength-dispersive (WD)
of 7.7–10.7 mm.
Determination of cell viability, toxicity, proliferation, and
chondrogenic differentiation using molecular methods
The viability tests were carried out using an MTT kit.
With the activity of dehydrogenase enzymes of viable
cell mitochondria, blue formazan crystals form from the
tetrazolium ring [1, 2, 27–30].
The cell viability and toxicity were analyzed in all
experimental groups at 0, 24, 48, and 72 h after the ap-
plication of the drug. Cell culture medium was discarded
and 100 μl of the MTT stock solution were added to all
the wells. Incubation for 150 min was then carried out
at 37 °C in a dark environment. Ten microliters of
DMSO was added and the samples were then incubated
for another 10 min at 37 °C. Afterwards, absorbance was
recorded at 540 nm (optical density (OD)) wavelength.
The cells viability of the control group before the ap-
plication of flurbiprofen was assumed to be 100 %. The
cell viability of drug administered groups was recorded
after 24, 48, and 72 h and compared with that of the
control group.
During the differentiation of human mesenchymal
stem cells containing embryonic stem cells, the SSEA-1
protein is upregulated, whereas it is downregulated in
cells lacking differentiation. To determine whether
SSEA-1 was increased or decreased in the cultured cells
in the drug treatment groups, a prechondrocytic human
characterization ELISA kit was used [31]. The analyses
were performed at 540 nm absorbance after 24, 48, and
72 h, using an ELISA reader.
Statistical analysis
Descriptive statistics are shown as the mean ± standard
deviation. In the analyses of the obtained data, results
were evaluated by cell number, MTT cell viability, tox-
icity, and proliferation, and SSEA-1 protein expression.
The Minitab R16 program was used in the statistical
evaluation. All the evaluations were made at the 95 %
confidence interval.
An analysis of variance (ANOVA) was conducted to
detect significant differences across the groups. In the
presence of differences across the groups, Tukey’s honest
significant difference (HSD) post hoc multiple pairwise
comparisons test was used to determine the difference
and investigate the false positive, so the different aver-
ages across the experiment groups were evaluated.
Pearson’s correlation test was used to determine
whether there was a direct relation between SSEA-1 ex-
pression and cell proliferation in the different subgroups.
Tukey’s test resulted in a yes/no response to the
Fig. 1 a–c Osteochondral tissue obtained during total knee replacement surgery. a Kellgren-Lawrence radiological scale grade IV.
b Osteochondral tissue samples. c Chondral tissue samples
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hypothesis (e.g., are there significant differences between
the wells, with p < 0.05). P < 0.01 was considered to be
highly significant.
Results
Evaluation of microscopic analyses
Cell viability and cell morphology were assessed by
inverted light microscopy. Different doses of flurbiprofen
(1–1000 μM) were applied to the cells for 24, 48, and
72 h, and microscopic changes were then recorded
(Fig. 2).
As the dose of cytotoxic agent increased, the cell
morphology changed, with the cells losing their specific
shapes and becoming round shaped. Higher doses
exerted greater effects on cell morphology than longer
durations of lower doses. The changes were microscop-
ically verified by ESEM and the MTT analyses.
In healthy chondrocytes showing chondroblastic ac-
tivity, the surface properties of the cells in the images
Fig. 2 Inverted light microscopy image, showing the round shape of the cells caused by cytotoxicity (black arrows)
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of the control group appeared normal. Viable cells
were observed 24, 48, and 72 h after the application
of flurbiprofen, but the viable cell concentration de-
creased with ascending doses. As shown by the ESEM
analysis, deterioration of cell surface morphologies
and loss of the extracellular matrix were evident in
chondrocyte cultures after the application of 1000 μM
of flurbiprofen (Fig. 3).
In all cases, dead cells were scattered throughout the
culture, with decreased numbers of dead and living cells.
In addition, the cell morphologies were altered, and the
cells appeared to be contracted and to have lost their
specific morphologies.
Statistical evaluation of MTT and SSEA-1 protein
expression
Cell viability, proliferation, and SSEA-1 protein expres-
sion values were lowest in the groups which flurbiprofen
was administered 72 h at 1000 mM dose. The lowest
toxicity rate was found in the group which 1 mM flurbi-
profen was administered at 24 h. These results were
Fig. 3 ESEM image of the surface morphology of the chondrocytes
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statistically significant (p < 0.01) (p < 0.01; Figs. 4 and 5,
Table 1).
In the control groups which no agent was adminis-
tered, cell viability, proliferation, and expression of
SSEA-1 protein were found to be increased in time. In
the experimental groups, viability, proliferation, and
SSEA-1 protein expression were found to be decreased
in comparison to the control groups. It was statistically
confirmed that the time of exposure to the drug was a
determinant in toxic effect (p = 0.037).
Discussion
In all fields of medicine, ongoing efforts are being made
to preserve the integrity of the healthy tissues or repair
them in case of an injury using either biological or surgi-
cal methods. Moreover, the possible toxic effects of
many frequently used drugs on the healthy or damaged
tissues are also being investigated.
Joint cartilage is usually destructed secondary to de-
generative disorders like osteoarthritis which are usually
associated with the interactions of traumatic, mechanic,
genetic, metabolic and biochemical factors and senility.
Similarly, cutting, or crushing the cartilage tissue within
the nasal septum during septoplasty or submucous re-
section operations were also reported to cause damage
in a part of the cartilage tissue [32]. In addition to these
factors, pharmaceutical preparations prescribed for the
patients for the treatment of various disorders were also
found to be responsible for the cartilage injury observed
in these populations. The importance of keeping the
integrity of the cartilage tissue was emphasized by many
authors in several studies [1–3, 22, 28–31, 33, 34].
Therefore, the authors of the present study aimed to
investigate the toxicity potential of a drug, flurbiprofen,
which is frequently prescribed by not only orthopaedists
and otorhinolaryngologists [8] but also other specialists,
on the human primary chondrocyte cultures at the
molecular level, in vitro.
As well as the structures within the joint cartilage is
concerned, the most vulnerable structure following in-
jury was reported to be the chondrocytes [33]. It was
also reported that the majority of the drugs administered
via different methods were found to accumulate in syn-
ovial fluids in significant concentrations [22, 34–36].
The cartilage tissue, however, is devoid of vascular,
lymphatic, or neural structures. Therefore, the cartilage
is nourished by either a perichondrium layer or a syn-
ovial fluid bathing the joint surface. Nutrients are
reached to the chondrocytes through a double diffusion
process. The nutrients (or drugs) first diffuse from the
synovial tissue to the synovial fluid. Following this, they
pass through the pores (6–8 nm in diameter) within the
structure of the cartilage and reach the chondrocytes
where a second diffusion takes place. In addition, a
pumping system, composed of active transport and
intermittent loading mechanisms, also have a significant
contribution to the nourishment or transport of mole-
cules to the chondrocytes.
Fig. 4 Change in the cell viability, toxicity, and proliferation
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The majority of drugs are composed of an organic acid
backbone and they have a high affinity to bind plasma
proteins. The pH value in the inflamed tissues is lower
than other parts of the body and the acidic milieu en-
ables rapid permeation of the plasma proteins into the
inflamed tissues. Hence, plasma protein-bound NSAID’s
readily accumulate at the sites of inflammation. Another
factor regarding the pharmacological property of
NSAID’S is their behavior in an acidic environment. As
the pH decreases, the concentration of lipid soluble and
non-ionized portion of the drug increases. Hence, the
interaction of the lipid structures of the cell membranes
is extended both in terms of duration and concentration
[11]. Finally, the cartilage tissue has a basic environment
and presence of an acidic synovial fluid in the vicinity
would be detrimental for the chondrocytes.
When limited number of studies in which cartilage
tissues or the chondrocyte directed toxicity was ana-
lyzed, it was found that they were carried out on animal
models. However, the reliability of the results of these
studies were questioned because the physiological re-
sponses and/or sensitivity of the tissues may be different
in human subjects. Instead of animal models, other simi-
lar researches was found to use commercial cell lines,
which are known to lose some genotypic and phenotypic
features that they had in human bodies [1–3, 29, 30].
For this very reason, we did not use commercial
cell lines. In this study, we used cartilage tissues
harvested from patients during a surgical operation.
During the application of knee prosthesis, primer
chondrocyte cultures were prepared from cells ob-
tained from undamaged chondral tissues of the
resected articular surface.
Thanks to the primary cultures composed of chondral
tissue obtained from the lateral compartment of the
human joint cartilage, in addition to the chondrocytes,
extensions like extracellular matrix could also be
analyzed.
Table 1 Statistical analyses; pairwise comparisons for SSEA-1
protein and MTT cell proliferation (grouping information using
the Tukey method and 95 % confidence interval)














bTukey’s HSD post hoc multiple pairwise comparisons test
Fig. 5 Change in the expression of SSEA-1
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To the best of our knowledge, the present study is the
first research that was conducted to assess the possible
chondrotoxic potential of a phenyl alkanoic acid deriva-
tive, flurbiprofen, on the primary chondrocyte cultures
of human, in vitro. For the first time, the structural
changes in the chondrocytes in response to long-term
exposure to the flurbiprofen, including loss of the integ-
rity of the extracellular matrix, detachment of the cells
from the surface of the cell-culture plates, and deform-
ation of the specific cell morphology to attain a rather
round appearance, could be observed in an in vitro
setting via invert light microscopy and environmental
scanning electron microscopy analysis (Figs. 2 and 3).
We did not only assess the viability, toxicity and prolif-
eration by analyzing mitochondrial activity at the
molecular level, but also assessed the level of chondro-
genic activity, which is used for determining the pre-
chondrocytic precursors, by measuring the extent of
SSEA-1 protein expression.
In all groups exposed to varying doses of flurbiprofen,
viability, proliferation, and SSEA-1 protein expression
were found to be decreased in comparison to the control
group. Duration of exposure was also proved to be a sta-
tistically significant factor in determining the degree of
toxicity (p = 0.037 and p < 0.01, respectively).
We are of the opinion that the data obtained from our
preliminary research may offer a new insight to the
future researches regarding this topic. When prescrib-
ing such type of drugs for their analgesic and anti-
inflammatory actions, their negative effects on the
chondrocyte viability and the integrity of the extracel-
lular matrix, in the long term, should be considered.
The present study has well based and strong in vitro
results. Its major limitation is that it does not sufficiently
reflect clinical setting. For this purpose, studies that
evaluate clinical outcomes in vivo are needed.
Conclusions
Phenyl alkanoic acid derivatives should not be used
unnecessarily and be prescribed only for definitive indi-
cations. The treatment should be completed within the
possible shortest time while the possible lowest dose is
administered under strict surveillance.
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